Treatment of splanchnic artery aneurysms – single center results and experience
Abstract
Background/Aim. Visceral artery aneurysms (VAAs) are rare but potentially life-threatening conditions. With the increasing availability of diagnostic and therapeutic options, there is a growing need to determine the optimal treatment approach–endovascular (EV) vs. open surgical (OS) reconstruction. The aim of this study was to analyze treatment outcomes in patients with VAA at a single center and compare the efficacy of EV and OS approaches. Methods. The study included 27 OS (the OS group) or EV (the EV group) interventions for VAA, performed at our institution from January 2010 to November 2023, on 27 patients, 13 males and 14 females, with a mean age of 57 ± 13 years. Treatment decisions were reached by a multidisciplinary team of a vascular surgeon, an anesthesiologist, and an interventional radiologist. Results. Out of the 27 patients, 9 were treated in the emergency setting, with 6 of them having ruptured aneurysms. The most common was a splenic artery aneurysm, 50.0% of all VAAs. Thirteen patients underwent EV reconstruction, one patient underwent a hybrid approach, and 13 patients had OS reconstruction. Technical success was 24/27 or 88.9%. Eleven patients were treated by coil embolization, while two were treated with the implantation of a covered stent. In the EV group, mortality was nil. In 14 patients, OS treatment was performed with 9 VAA resections and arterial reconstructions (7 with Dacron graft, 1 with polytetrafluoroethylene graft, and 1 with autovenous graft), with 2 splenectomies and 3 aneurysm exclusions. Two patients died intraoperatively due to severe bleeding, and one after the procedure because of intestinal ischemic complications. Mean duration of hospitalization after OS or EV procedure was 7.43 and 4.92 days, respectively. Conclusion. Treating patients using the EV approach is safe, with less invasiveness and shorter hospital stays, suitable for elective and emergency cases when technically feasible. OS remains a reliable option at high-volume centers, particularly for complex cases unsuitable for EV approaches or in low-risk patients. Treatment decision should be guided by VAA characteristics (size, symptoms, location, morphology), patient comorbidities, and specific clinical context, such as prior abdominal surgeries.
References
Batagini NC, Constantin BD, Kirksey L, Vallentsits Estenssoro AE, Puech Leão P, De Luccia N, et al. Natural history of splanchnic artery aneurysms. Ann Vasc Surg 2021; 73: 290–5. DOI: 10.1016/j.avsg.2020.10.047.
Lynch MJ, Woodford NW. Rupture of a splenic artery aneurysm during pregnancy with maternal and foetal death: a case re-port. Med Sci Law 2008; 48(4): 342–5. DOI: 10.1258/rsmmsl.48.4.342.
Paul M. A large traumatic aneurysm of the hepatic artery. Br J Surg 1951; 39(155): 278–80. DOI: 10.1002/bjs.18003915518.
Davidović LB, Marković MD, Bjelović MM, Cvetković SD. Splanchnic artery aneurysms. Srp Arh Celok Lek 2006; 134(7–8): 283–9. DOI: 10.2298/SARH0608283D. (Serbian)
Popov P, Boskovic S, Sagic D, Radevic B, Ilijevski N, Nenezic D, et al. Treatment of visceral artery aneurysms: retrospective study of 35 cases. Vasa 2007; 36(3): 191–8. DOI: 10.1024/0301-1526.36.3.191.
Ilić N, Banzić I, Šteković J, Končar I, Davidović L, Fatić N. Multi-ple visceral artery aneurysms. Ann Vasc Surg 2015; 29(6): 1318.e7–e10. DOI: 10.1016/j.avsg.2015.02.026.
Miani S, Arpesani A, Giorgetti PL, Rampoldi V, Giordanengo F, Ruberti U. Splanchnic artery aneurysms. J Cardiovasc Surg (Torino) 1993; 34(3): 221–8.
Batagini NC, El Arousy H, Clair DG, Kirksey L. Open versus endovascular treatment of visceral artery aneurysms and pseu-doaneurysms. Ann Vasc Surg 2016; 35: 1–8. DOI: 10.1016/j.avsg.2016.01.035.
Chaer RA, Abularrage CJ, Coleman DM, Eslami MH, Kashyap VS, Rockman C, et al. The Society for Vascular Surgery clinical practice guidelines on the management of visceral aneurysms. J Vasc Surg 2020; 72(Suppl 1): 3S–39S. DOI: 10.1016/j.jvs.2020.01.039.
Carr SC, Mahvi DM, Hoch JR, Archer CW, Turnipseed WD. Vis-ceral artery aneurysm rupture. J Vasc Surg 2001; 33(4): 806–11. DOI: 10.1067/mva.2001.112320.
Barrionuevo P, Malas MB, Nejim B, Haddad A, Morrow A, Ponce O, et al. A systematic review and meta-analysis of the man-agement of visceral artery aneurysms. J Vasc Surg 2019; 70(5): 1694–9. DOI: 10.1016/j.jvs.2019.02.024.
Deterling RA Jr. Aneurysm of the visceral arteries. J Cardio-vasc Surg (Torino) 1971; 12(4): 309–22.
Grego FG, Lepidi S, Ragazzi R, Iurilli V, Stramanà R, Deriu GP. Visceral artery aneurysms: a single center experience. Cardio-vasc Surg 2003; 11(1): 19–25. DOI: 10.1016/S0967-2109(02)00121-7.
Hong Z, Chen F, Yang J, Wu Z, Yan Z. Diagnosis and treatment of splanchnic artery aneurysms: a report of 57 cases. Chin Med J 1999; 112(1): 29–33. DOI: 10.5555/cmj.0366-6999.112.01.p29.01.
Jørgensen BA. Visceral artery aneurysms: a review. Dan Med Bull 1985; 32(4): 237–42.
Bedford PD, Lodge B. Aneurysm of the splenic artery. Gut 1960; 1(4): 312–20. DOI: 10.1136/gut.1.4.312.
Mattar SG, Lumsden AB. The management of splenic artery aneurysms: experience with 23 cases. Am J Surg 1995; 169(6): 580–4. DOI: 10.1016/S0002-9610(99)80225-6.
Manenti F, Williams R. Injection studies of the splenic vascula-ture in portal hypertension. Gut 1966; 7(2): 175–80. DOI: 10.1136/gut.7.2.175.
Stanley JC, Fry WJ. Pathogenesis and clinical significance of splenic artery aneurysms. Surgery 1974; 76(6): 898–909.
Stanley JC, Gewertz BL, Bove EL, Sottiurai V, Fry WJ. Arterial fibrodysplasia: histopathologic character and current etiologic concepts. Arch Surg 1975; 110(5): 561–6. DOI: 10.1001/archsurg.1975.01360110107018.
Boijsen E, Efsing HO. Aneurysm of the splenic artery. Acta Ra-diol Diagn (Stockh) 1969; 8(1): 29–41. DOI: 10.1177/028418516900800105.
Feist JH, Gajaraj A. Extra and intrasplenic artery aneurysms in portal hypertension. Radiology 1977; 125(2): 331–4. DOI: 10.1148/125.2.331.
Gaglio PJ, Regenstein F, Slakey D, Cheng S, Takiff H, Rinker R, et al. Alpha 1 antitrypsin deficiency and splenic artery aneu-rysm rupture: an association? Am J Gastroenterol 2000; 95(6): 1531–4. DOI: 10.1111/j.1572-0241.2000.02090.x.
Scheinin TM, Vänttinen E. Aneurysms of the splenic artery in portal hypertension. Ann Clin Res 1969; 1(3): 165–8.
Puttini M, Aseni P, Brambilla G, Belli L. Splenic artery aneu-rysms in portal hypertension. J Cardiovasc Surg (Torino) 1982; 23(6): 490–3.
Lee PC, Rhee RY, Gordon RY, Fung JJ, Webster MW. Manage-ment of splenic artery aneurysms: the significance of portal and essential hypertension. J Am Coll Surg 1999; 189(5): 483–90. DOI: 10.1016/S1072-7515(99)00168-4.
Yoon HK, Lindh M, Uher P, Lindblad B, Ivancev K. Stent graft repair of a splenic artery aneurysm. Cardiovasc Intervent Ra-diol 2001; 24(3): 200–3. DOI: 10.1007/PL00021044.
Patel JV, Weston MJ, Kessel DO, Prasad R, Toogood GJ, Robertson I. Hepatic artery pseudoaneurysm after liver transplantation: treatment with percutaneous thrombin injection. Transplanta-tion 2003; 75(10): 1755–7. DOI: 10.1097/01.TP.0000063936.94587.10.
Cowan S, Kahn MB, Bonn J, Becker GJ, Dimuzio P, Leichter R, et al. Superior mesenteric artery pseudoaneurysm successfully treated with a polytetrafluoroethylene covered stent. J Vasc Surg 2002; 35(4): 805–7. DOI: 10.1067/mva.2002.121754.
Shumacker HB Jr, Siderys H. Excisional treatment of aneurysm of the celiac artery. Ann Surg 1958; 148(6): 885–9. DOI: 10.1097/00000658-195812000-00003.
Violago FC, Downs AR. Ruptured atherosclerotic aneurysm of the superior mesenteric artery with celiac axis occlusion. Ann Surg 1971; 174(2): 207–10. DOI: 10.1097/00000658-197108000-00006.
Stanley JC, Frey CF, Miller TA, Lindenauer SM, Child CG 3rd. Major arterial hemorrhage: a complication of pancreatic pseu-docysts and chronic pancreatitis. Arch Surg 1976; 111(4): 435–40. DOI: 10.1001/archsurg.1976.01360220131022.
De Bakey ME, Cooley DA. Successful resection of a mycotic aneurysm of the superior mesenteric artery: case report and review of the literature. Am Surg 1953; 19(2): 202–12.
Koelemay MJ, Geelkerken RH, Kärkkäinen J, Leone N, de Bruin JL, Gombert A, et al. European Society for Vascular Surgery (ESVS) 2025 clinical practice guidelines on the management of diseases of the mesenteric and renal arteries and veins. Eur J Vasc Endovasc Surg 2025; 70(2): 153–218. DOI: 10.1016/j.ejvs.2025.06.010.
Pratesi C, Esposito D, Martini R, Novali C, Zaninelli A, Annese AL, et al. Guidelines on the diagnosis, treatment and man-agement of visceral and renal arteries aneurysms: a joint as-sessment by the Italian Societies of Vascular and Endovascular Surgery (SICVE) and Medical and Interventional Radiology (SIRM). J Cardiovasc Surg (Torino) 2024; 65(1): 49–63. DOI: 10.23736/S0021-9509.23.12809-6.
Stone WM, Abbas MA, Gloviczki P, Fowl RJ, Cherry KJ. Celiac arterial aneurysms: a critical reappraisal of a rare entity. Arch Surg 2002; 137(6): 670–4. DOI: 10.1001/archsurg.137.6.670.
Rebelo A, Ronellenfitsch U, Partsakhashvili J, Kleeff J, John E, Ukkat J. Visceral aneurysms: systematic review and meta anal-ysis of endovascular versus open repair. Angiology 2024; 75(6): 546–55. DOI: 10.1177/00033197231164286.
Fargion AT, Falso R, Speziali S, Biancofiore B, Esposito D, Giaco-melli E, et al. Results of current endovascular treatments for visceral artery aneurysms. J Vasc Surg 2023; 78(2): 387–93. DOI: 10.1016/j.jvs.2023.04.040.
Khairallah MK, Morgan RA, Das R. Technical considerations of endovascular management of true visceral artery aneurysms. CVIR Endovasc 2023; 6(1): 31. DOI: 10.1186/s42155-023-00368-9.
Gong C, Sun MS, Leng R, Ren HL, Zheng K, Wang SX, et al. Endovascular embolization of visceral artery aneurysm: a ret-rospective study. Sci Rep 2023; 13: 6936. DOI: 10.1038/s41598-023-33789-6.
Yanar F, Canbay Torun B, İlhan B, Gok AFK, Azamat İF, Sengun B, et al. Endovascular and surgical management of splenic ar-tery aneurysms. Ulus Travma Acil Cerrahi Derg 2024; 30(1): 38–42. DOI: 10.14744/tjtes.2023.23793.
